Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, April 24, 2019
Arrowhead has begun dosing in a new triple combination cohort that includes JNJ-3989 and additional undisclosed agents selected by Janssen in its ongoing Phase 1/2 study in patients with chronic HBV.
read more
Wednesday, August 01, 2018
Arrowhead Pharmaceuticals has earned a $10 million milestone payment from Amgen following the administration of the first dose of AMG 890, formerly referred to as ARO-LPA, in a clinical study.
read more
Arsenal Capital Partners has agreed to sell its portfolio company, Certara to EQT VII Fund for an enterprise value of $850 million.
read more
Wednesday, February 26, 2020
Arsenal has announced the acquisition of BresMed, a provider of health economic research, communications, and consulting services.
read more
Artelo Biosciences has expanded its existing research and worldwide commercial license agreement with The Research Foundation For The State University of New York, Stony Brook.
read more
Tuesday, January 09, 2024
Artelo Biosciences, Inc., a clinical-stage pharmaceutical company dedicated to modulating lipid-signaling pathways for developing treatments targeting cancer, pain, and neurological conditions, has chosen Worldwide Clinical Trials, a global contract ...
read more
Tuesday, October 29, 2019
Artelo Biosciences has selected Aptus Clinical as its CRO for the Company’s Phase 1b/2a randomized, placebo-controlled trial of ART27.13.
read more
Wednesday, March 15, 2023
Artisan Bio announced an extension of its research collaboration with Takeda which leverages Artisan's genome editing technology. The amended agreement builds on the companies' initial research program established in 2020 with a new research plan ...
read more
ARTMS and Telix have entered into a development collaboration agreement to employ ARTMS’ high activity production of Gallium-68 for Telix’s prostate cancer imaging product TLX591-CDx for imaging of prostate cancer with PET.
read more
Monday, February 10, 2020
Certara announced its discovery research relationship with Arvinas has expanded to include a greater diversity of small molecule drug discovery projects and data sources.
read more
Wednesday, November 15, 2017
Arvinas has expanded its ongoing license agreement with Genentech for the development of new therapeutics using Arvinas' novel PROTAC technology.
read more
Asahi Kasei Bioprocess America and GeminiBio entered into a strategic partnership to advance the application of inline buffer formulation (IBF) in the biopharmaceutical industry.
read more
Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide therapeutics. The partners will collaborate to build a cutting-edge oligonucleotide cGMP ...
read more
Asahi Kasei Bioprocess (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide therapeutics. The partners will collaborate to build a cutting-edge oligonucleotide cGMP ...
read more
Asahi Kasei has established Asahi Kasei Life Science, a new organizational structure dedicated to its bioprocess businesses. This move reflects the company’s commitment to addressing the evolving needs of the pharmaceutical industry by enhancing ...
read more